A Study to Investigate HLA-G Targeted Exosome (SOB100) in Healthy Subjects

Clinical trial NCT07219940 · RECRUITING

Trial details

NCT number: NCT07219940
Sponsor: Shine-On Biomedical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Exosome Targeted Therapy

Start date: 2025-12-01
Primary completion: 2026-12-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.